Zepatier Tablet, Film Coated
Product Images NDC 0006-3074

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zepatier (NDC 0006-3074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zepatier 01)

Chemical structure diagram of the active ingredients elbasvir and grazoprevir in ZEPATIER, showing the molecular arrangement of atoms and bonds.*

FDA Label Image

Chemical Structure (Zepatier 02)

Chemical structure diagram of the active ingredient elbasvir, shown with molecular bonds and functional groups clearly depicted.*

FDA Label Image

Principal Display Panel (50 mg/100 mg Tablet Dose Pack Carton)

Packaging label for Zepatier tablets containing elbasvir and grazoprevir at a strength of 50 mg/100 mg. The label indicates 28 film-coated tablets per carton with 2 dose packs, each containing 14 tablets. The product is marked for prescription use only and is labeled by Merck Sharp & Dohme LLC. The label features the NDC 0006-3074-02 and a visual of an oblong beige tablet imprinted with '770'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.